Antibodies of EIF3D


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
EIF3DProduct_ID: A301-758A
Lot_ID: 1
Source: Bethyl Labs
Target Name: EIF3D-human		 HepG2_Bethyl_A301-758A_1_EIF3D.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using EIF3D specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-EIF3D antibody (lanes under 'EIF3D').
 EIF3D_Secondary_Western.png<br>Caption: Western blot following shRNA against EIF3D in K562 and HepG2 whole cell lysate using EIF3D specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against EIF3D. Lanes 5-7 follow the same pattern, but in HepG2. EIF3D protein appears as the green band, GAPDH serves as a control and appears in red.
 EIF3D_Secondary_Western.png<br>Caption: Western blot following shRNA against EIF3D in K562 and HepG2 whole cell lysate using EIF3D specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against EIF3D. Lanes 5-7 follow the same pattern, but in HepG2. EIF3D protein appears as the green band, GAPDH serves as a control and appears in red.